50% Of This MoonLake Immunotherapeutics Insider's Holdings Were Sold

Simply Wall StOct 24 11:36 ET

H.C. Wainwright Maintains MoonLake Immunotherapeutics(MLTX.US) With Buy Rating, Maintains Target Price $100

Moomoo NewsOct 15 06:31 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Pharming Group (PHAR) and MoonLake Immunotherapeutics (MLTX)

TipRanksOct 15 06:20 ET · Ratings

Insider Trading Activity Heats Up: Tuesday's Top Buys and Sells in US Stocks

InvestingOct 9 09:30 ET

Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics

Yahoo FinanceOct 8 21:11 ET

MoonLake Immunotherapeutics(MLTX.US) 10% Shareholder Sells US$100 Million in Common Stock

Moomoo NewsOct 8 18:52 ET